Market revenue in 2022 | USD 977.8 million |
Market revenue in 2030 | USD 1,618.6 million |
Growth rate | 6.5% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 96.61% in 2024. Horizon Databook has segmented the Latin America menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The average age of undergoing menopause transition is early in the region, as compared to western nations. Although the prevalence of menopausal symptoms such as hot flashes is moderate in the region, the change in lifestyle and food habits is contributing to the growing adoption of dietary supplements for menopause to meet nutritional requirements.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account